Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012–2017: Implications for policy and regulatory change Format Наборы инструментов Themes Policy Practice https://ijhpr.biomedcentral.com/articles/10.1186/s13584-020-00369-2